Curaleaf Holdings (CURLF) Other Working Capital Changes (2019 - 2024)
Curaleaf Holdings (CURLF) recorded quarterly Other Working Capital Changes of $6.0 million in Q4 2024, up 323.74% quarter-over-quarter from -$2.7 million in Q3 2024, and up 776.82% on a YoY basis from $679274.2 in Q1 2024.
Curaleaf Holdings (CURLF) Other Working Capital Changes (2019 - 2024) Analysis & Trends
Curaleaf Holdings' Other Working Capital Changes history runs 6 years deep, the most recent figure standing at $6.0 million for Q4 2024.
- In Q4 2024, Other Working Capital Changes rose 776.82% year-over-year to $6.0 million; the TTM figure through Dec 2024 stood at $938000.0 (down 95.67% YoY), while the FY2025 annual figure was -$17.9 million, down 439.87% from the prior year.
- Other Working Capital Changes was $6.0 million for Q4 2024 at Curaleaf Holdings, up from -$2.7 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $36.6 million in Q4 2021 to a low of -$17.1 million in Q1 2022.
- Historically, Other Working Capital Changes has averaged -$2.2 million across 5 years, with a median of -$3.1 million in 2020.
- Biggest YoY gain for Other Working Capital Changes was 1716.41% in 2021; the steepest drop was 276.69% in 2021.
- A 5-year view of Other Working Capital Changes shows it stood at -$2.3 million in 2020, then soared by 1716.41% to $36.6 million in 2021, then plunged by 105.2% to -$1.9 million in 2022, then surged by 53.78% to -$880000.0 in 2023, then jumped by 776.82% to $6.0 million in 2024.
- The last three Other Working Capital Changes figures came in at $6.0 million (Q4 2024), -$2.7 million (Q3 2024), and -$880000.0 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 5.96 Mn |
| Dec 31, 2024 | 5.96 Mn |
| Sep 30, 2024 | -2.66 Mn |
| Sep 30, 2024 | -2.66 Mn |
| Dec 31, 2023 | -880,000.00 |
| Dec 31, 2023 | -880,000.00 |
| Sep 30, 2023 | -1.48 Mn |
| Sep 30, 2023 | -1.48 Mn |
| Dec 31, 2022 | -1.90 Mn |
| Dec 31, 2022 | -1.90 Mn |
| Sep 30, 2022 | 25.92 Mn |
| Sep 30, 2022 | 25.92 Mn |
| Jun 30, 2022 | -12.24 Mn |
| Jun 30, 2022 | -12.24 Mn |
| Mar 31, 2022 | -17.08 Mn |
| Mar 31, 2022 | -17.08 Mn |
| Dec 31, 2021 | 36.64 Mn |
| Dec 31, 2021 | 36.64 Mn |
| Sep 30, 2021 | -15.07 Mn |
| Sep 30, 2021 | -15.07 Mn |